Full year revenues were up 13 percent, reaching $520.5 million in 2011. The company attributes its success to its “market-share taking strategy,” which drove an increase in revenue despite a challenging spine market in the United States. The company pioneered instrumentation for the lateral approach to the spine in a procedure called eXtreme Lateral Interbody Fusion.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Spine Devices:
SI-BONE Receives Patent for Broad Method Claims
Amedica Launches New Spinal Fusion Device
19 Spine Devices Receive FDA 510(k) Clearance in January
NuVasive Reports 16.2% Increase in 4Q Revenue to $150.2M
NuVasive, a minimally disruptive spine device company, recently reported fourth quarter 2011 revenue at $150.2 million, a 16.2 percent increase from the same period last year, according to a company news release.
